Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Biochem Biophys Res Commun. Author manuscript; available in PMC 2011 Feb 26.
Published in final edited form as:
PMCID: PMC2830356

Neutrophils are significant producers of IL-10 during sepsis


Sepsis is a syndrome involving systemic inflammation as well as an infectious focus. Accordingly, the host immune response to sepsis involves complex leukocyte interplay that is incompletely understood. It is known that the immunoregulatory cytokine, IL-10, is rapidly expressed during the early stages of sepsis. In a murine model of sepsis, we sought to elucidate which leukocytes are early IL-10 producers. Using a novel IL-10 transcriptional reporter mouse, we observed that splenic leukocytes produced little IL-10. At the site of infection, peritoneal neutrophils produced the highest levels of IL-10 among leukocytes. Using cytokine antibody labeling, we further show that peritoneal neutrophils had high amounts of intracellular IL-10. We next depleted neutrophils and found a 40% decrease in peritoneal IL-10 levels. Altogether, this report demonstrates that among leukocytes, neutrophils are significant contributors of IL-10 at the site of infection during sepsis.

Keywords: sepsis, inflammation, neutrophil, IL-10


Sepsis is defined as the systemic inflammatory response directed against an infectious focus. It remains a difficult syndrome to treat, in part, due to the complexity of the immune response. Among the numerous cytokines and chemokines produced during sepsis, IL-10 is a potent immunoregulatory molecule. The consequences of IL-10 on the immune response include: the down-regulation of key signaling receptors on antigen presenting cells such as CD40, CD80, CD86 and MHC II, decreased Mac-1 expression [1] and inhibition of neutrophil oxidative burst [2], suppression of T cell proliferation and IL-2, IL-6 and IFN-γ production, the maintenance of FoxP3 expression in regulatory T cells, and suppression of NK cell function [3].

During sepsis, blockade of IL-10 by neutralizing antibodies was shown to decrease survival and increase neutrophil accumulation. Additionally, it was found that IL-10 reduced NK activation and IFN-γ production [3]. Another study investigated the use of the nontoxic immunomodulator, AS101, which is known to inhibit IL-10 expression [4]. When AS101 was administered 12 hours following sepsis induction, survival was improved. Consistent with this, AS101 increased MHC II expression on APCs, T cell IFN-γ production, and bacterial clearance, while decreasing tissue damage. Thus, the timing for IL-10 neutralization in order to improve the host response during sepsis is critical. Finally, it was found that during sepsis, the combination of infectious focus removal and administration of recombinant IL-10 decreased mortality and serum IL-6, while increasing T cell responsiveness [5].

A large number of leukocytes, including monocytes/macrophages, dendritic cells, neutrophils, natural killer cells, eosinophils, T and B cells, as well as nonimmune cells such as keratinocytes and hepatocytes, can express IL-10 [6; 7; 8; 9; 10; 11]. However, despite the importance of IL-10 during sepsis, leukocyte contributions towards IL-10 production and accumulation are not completely understood. Here, we utilized a novel IL-10 transcriptional reporter mouse and antibody labeling to determine that significant numbers of neutrophils produce IL-10 at the site of infection. Additionally, using neutrophil depleting antibodies, we determined the net neutrophil contribution to IL-10 concentrations at the site of infection.

Materials and Methods

Cecal ligation and puncture

Homebred male C57BL/6 (WT) and IL-10 transcriptional reporter (Vert-X) [12] mice between 6 and 8 weeks of age were utilized. The Vert-X mice were a generous gift from the Christopher L. Karp laboratory. All experiments involving animals were performed under protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Cincinnati. Polymicrobial sepsis was induced with an 80% cecal ligation and a single puncture using a 23 gauge needle as previously described [13].

Neutrophil Depletion

Mice were injected intraperitoneally (i.p.) with 150 μg RB6-8C5 mAb or rat IgG as a control 36 hours prior to CLP [14]. Pilot experiments demonstrated depletion of blood neutrophils after 36 hours (data not shown).

Flow cytometry for surface and intracellular staining

Analyses of cell surface antigen expression and in situ cytokine expression were performed as previously described on the peritoneal lavage samples [15]. Flow cytometry data acquisition and analysis were performed on LSR II using FACS Diva software (Becton Dickinson, Mountain View, CA). After blockade of Fc receptors with CD16/32 blocking Ab (BD Pharmingen, San Diego, CA), leukocytes were labeled using mAbs to the following antigens: CD11b (BD Pharmingen), Gr-1 (Clone: RB6-8C5, BD Pharmingen), Ly-6G (Clone: 1A8, BD Pharmingen), CD4 (Clone: RM4–5, BioLegend, San Diego, CA), CD8 (Clone: 53-6.7, BD Pharmingen), F4/80 (clone: 6F12, BD Pharmingen), IL-10 (Clone: JES5-16E3, BioLegend) and anti-neutrophil (Clone: 7/4, AbD Serotec, Raleigh, NC).

IL-10 measurement by ELISA

Peritoneal lavage was obtained by injection of 9 ml 0.9% normal saline intraperitoneally and removal via syringe. IL-10 (BD Pharmingen) levels were analyzed using the manufacturer’s protocol [16].

Statistical Analyses

Statistical comparisons were performed using Student t Test using StatView 3.5 (SAS Institute, Cary, NC). The mean and standard error of the mean were calculated in experiments containing multiple data points. A value of P ≤ 0.05 was considered statistically significant.


In order to determine IL-10 producing cells during sepsis, Vert-X mice underwent either sham- or CLP-surgeries. Peritoneal and splenic leukocytes isolated from sham-operated mice did not express GFP (data not shown). In septic Vert-X mice, we analyzed splenic macrophages, CD4, CD8 and B cells (Figure 1A) as well as peritoneal neutrophils, macrophages, and T cells (Figure 1B) for GFP expression 24 hours after CLP. Of these cells, peritoneal neutrophils exhibited the highest levels of GFP, while macrophages exhibited moderate levels of GFP. Alternatively, we collected peritoneal leukocytes from CLP-operated wild type mice and determined IL-10 production by intracellular cytokine labeling. By this technique, we observed that peritoneal neutrophils from septic mice exhibited significant IL-10 production using this alternative method (Figure 1C). Altogether, using two distinct methodologies, we demonstrate that neutrophils are a significant producer of IL-10 during the first 24 hours after CLP.

Figure 1
Peritoneal neutrophils are observed to produce IL-10 by two methodologies

In order to define the amount of IL-10 produced by neutrophils during early sepsis, we utilized anti-Gr-1 antibodies to deplete neutrophils prior to CLP. Isotype- and anti-Gr-1-treated mice then underwent CLP. Using two distinct neutrophil-labeling panels, we observed that 24 hours after CLP the proportion of peritoneal neutrophils is decreased between the two treatments (Figures 2A–D). Enumeration of flow cytometric data 6 and 24 hours after CLP demonstrate a greater than 95% depletion of neutrophils in the Gr-1-treated mice compared to the isotype-treated mice (Figure 2E). Finally, 24 hours after CLP, we observed an approximate 40% decrease of peritoneal IL-10 concentrations isolated from neutrophil depleted septic mice. Thus, neutrophils are significant producers of IL-10 during the first 24 hours of sepsis.

Figure 2
Neutrophil depleted mice accumulate decreased peritoneal IL-10


IL-10 is an important immunoregulatory cytokine involved in controlling inflammation during sepsis. In this report, we utilized the CLP model, which is currently considered the “gold standard”, to induce sepsis [17]. During sepsis, we observed little IL-10 production by splenic and peritoneal lymphocytes, and significant IL-10 production by myeloid cells, particularly neutrophils (Figure 1).

Previously, it has been shown that neutrophils isolated from burn patients could express IL-10, while neutrophils isolated from healthy controls could not [18]. As burn patients are more susceptible to infections, this suggests that burn-trauma increases numbers of neutrophils with potentially pathogenic immunosuppressive properties. Signaling mechanisms responsible for this altered phenotype have not been fully elucidated, but may include inflammation-induced mediators such as GM-CSF and TNF-α. It has been reported that when treated with TNF-α, neutrophils from wild type mice, but not TNF-α receptor deficient mice, had significantly increased p38 MAPK phosphorylation [19]. It is well established that TNF-α is increased during sepsis and this likely results in increased active p38 in neutrophils. Additionally, active p38 is known to control IL-10 production [20]. Thus, increased inflammation may enhance IL-10 production through a p38-dependent mechanism.

High systemic levels of IL-10 have been reported as predictive for increased mortality, while moderate levels of IL-10 are associated with low mortality [21]. At the site of infection, one of the most abundant leukocytes is the neutrophil and we demonstrate that these cells are significant IL-10 producers (Figure 2). It has been demonstrated that depleting neutrophils at different time points produces significantly divergent results [22]. When neutrophils were depleted prior to CLP, there were substantial increases in bacteremia, along with increases in ALT, AST, and BUN that suggested increased liver and kidney tissue injury. In contrast, when neutrophils were depleted 12 h after CLP, there were dramatic reductions in levels of bacteremia, reduced liver and renal dysfunction, and decreased mortality [22]. These data suggest that initial neutrophil activity is protective for the host response to sepsis, while later actions are pathogenic. We speculate that during the intense sepsis-associated inflammation the environment alters or switches the neutrophil phenotye such that the cells start to produce IL-10. Experiments to determine, 1) the time point when neutrophils start to produce IL-10, 2) whether neutrophil IL-10 production can be used as a clinical prognostic indicator, and 3) the role of p38 in neutrophil IL-10 production are in progress.

In summary, our data indicate that among leukocytes in the spleen or at the site of infection, neutrophils are significant producers of IL-10 during sepsis. As IL-10 is a potential therapeutic target for sepsis, this report provides significant insight into its mode of production.


Award number R01GM072760 (CCC) and 5K08GM084143-02 (JTM) from the National Institute of General Medical Sciences supported the project described. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


1. Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol. 2009;183:7557–68. [PubMed]
2. Dang PM, Elbim C, Marie JC, Chiandotto M, Gougerot-Pocidalo MA, El-Benna J. Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J. 2006;20:1504–6. [PubMed]
3. Scott MJ, Hoth JJ, Turina M, Woods DR, Cheadle WG. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine. 2006;33:79–86. [PubMed]
4. Kalechman Y, Gafter U, Gal R, Rushkin G, Yan D, Albeck M, Sredni B. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention. J Immunol. 2002;169:384–92. [PubMed]
5. Manley MO, O’Riordan MA, Levine AD, Latifi SQ. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock. 2005;23:521–6. [PubMed]
6. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765. [PubMed]
7. Alfrey EJ, Most D, Wang X, Lee LK, Holm B, Krieger NR, Sibley RK, Huie P, Dafoe DC. Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation. Surgery. 1995;118:399–404. discussion 404–5. [PubMed]
8. Becherel PA, LeGoff L, Frances C, Chosidow O, Guillosson JJ, Debre P, Mossalayi MD, Arock M. Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3′,5′-monophosphate-dependent mechanism. J Immunol. 1997;159:5761–5. [PubMed]
9. Das G, Augustine MM, Das J, Bottomly K, Ray P, Ray A. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A. 2003;100:5324–9. [PMC free article] [PubMed]
10. Kayaba H, Dombrowicz D, Woerly G, Papin JP, Loiseau S, Capron M. Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol. 2001;167:995–1003. [PubMed]
11. Romani L, Mencacci A, Cenci E, Spaccapelo R, Del Sero G, Nicoletti I, Trinchieri G, Bistoni F, Puccetti P. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol. 1997;158:5349–56. [PubMed]
12. Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, Trompette A, Yogev N, Gu Y, Khodoun M, Hildeman D, Boespflug N, Fogolin MB, Grobe L, Greweling M, Finkelman FD, Cardin R, Mohrs M, Muller W, Waisman A, Roers A, Karp CL. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol. 2009;183:2312–20. [PMC free article] [PubMed]
13. Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O’Reilly M, Remick DG. Immunopathologic responses to non-lethal sepsis. Shock. 1999;12:118–26. [PubMed]
14. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol. 1994;152:1836–46. [PubMed]
15. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol. 2001;167:6140–9. [PubMed]
16. Tschop J, Martignoni A, Goetzman HS, Choi LG, Wang Q, Noel JG, Ogle CK, Pritts TA, Johannigman JA, Lentsch AB, Caldwell CC. Gammadelta T cells mitigate the organ injury and mortality of sepsis. J Leukoc Biol. 2008;83:581–8. [PMC free article] [PubMed]
17. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81:137–43. [PubMed]
18. Tsuda Y, Shigematsu K, Kobayashi M, Herndon DN, Suzuki F. Role of polymorphonuclear neutrophils on infectious complications stemming from Enterococcus faecalis oral infection in thermally injured mice. J Immunol. 2008;180:4133–8. [PubMed]
19. Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. Shock. 2006;26:69–76. [PubMed]
20. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, Brennan FM. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol. 1998;160:920–8. [PubMed]
21. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol. 2006;177:1967–74. [PubMed]
22. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA. Harmful and protective roles of neutrophils in sepsis. Shock. 2005;24:40–7. [PubMed]
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene
    Gene records that cite the current articles. Citations in Gene are added manually by NCBI or imported from outside public resources.
  • GEO Profiles
    GEO Profiles
    Gene Expression Omnibus (GEO) Profiles of molecular abundance data. The current articles are references on the Gene record associated with the GEO profile.
  • HomoloGene
    HomoloGene clusters of homologous genes and sequences that cite the current articles. These are references on the Gene and sequence records in the HomoloGene entry.
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...